PRODUCTION OF SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR-TYPE-I IN ESCHERICHIA-COLI - OPTIMIZATION OF THE REFOLDING YIELDS BY A MICROTITER DILUTION ASSAY

被引:9
作者
MERLI, S [1 ]
CORTI, A [1 ]
CASSANI, G [1 ]
机构
[1] SAN RAFFAELE H SCI INST,DIBIT,MILAN,ITALY
关键词
D O I
10.1006/abio.1995.1441
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
In this study optimization of the soluble tumor necrosis factor receptor type I (sTNF-RI) refolding by the use of a micro-renaturation assay in 96-well microplates is described. Microplate wells were filled with buffers varying in pH and urea and substrate concentration. Denatured and reduced sTNF-RI was then rapidly diluted and allowed to refold for a variable time at different temperatures. The extent of renaturation was measured by a sandwich enzyme-linked immunosorbent assay (ELISA), based on the use of two monoclonal antibodies obtained against urinary sTNF-RI. Among about 100 different combinations tested, a maximum refolding yield of 21.5% has been obtained in 100 mM Tris, pH 8-8.5, 1 mM EDTA, 0.1% bovine serum albumin, 2 M urea, at a denatured protein concentration of 10 mu g/ml and at 26 degrees C. Folded sTNF-RI was purified by batchwise immunoaffinity chromatography and its activity evaluated by immunological and biological assays, A good correlation was observed between the data obtained with different assays (biological assay, ligand-directed ELISA, and double-determinant sandwich ELISA) indicating that the refolded receptor has gained biological and immunological reactivity comparable to those of the soluble TNF-receptor type I expressed in eukaryotic cells. (C) 1995 Academic Press, Inc.
引用
收藏
页码:85 / 91
页数:7
相关论文
共 25 条
[1]   CRYSTAL-STRUCTURE OF THE SOLUBLE HUMAN 55 KD TNF RECEPTOR-HUMAN TNF-BETA COMPLEX - IMPLICATIONS FOR TNF RECEPTOR ACTIVATION [J].
BANNER, DW ;
DARCY, A ;
JANES, W ;
GENTZ, R ;
SCHOENFELD, HJ ;
BROGER, C ;
LOETSCHER, H ;
LESSLAUER, W .
CELL, 1993, 73 (03) :431-445
[2]   A METHOD FOR INCREASING THE YIELD OF PROPERLY FOLDED RECOMBINANT FUSION PROTEINS - SINGLE-CHAIN IMMUNOTOXINS FROM RENATURATION OF BACTERIAL INCLUSION-BODIES [J].
BUCHNER, J ;
PASTAN, I ;
BRINKMANN, U .
ANALYTICAL BIOCHEMISTRY, 1992, 205 (02) :263-270
[3]  
CORTI A, 1994, LYMPHOKINE CYTOK RES, V13, P183
[4]   IDENTIFICATION OF 2 FORMS (31-33-KD AND 48-KD) OF THE URINARY SOLUBLE P55 TUMOR-NECROSIS-FACTOR RECEPTOR THAT ARE DIFFERENTIALLY N-GLYCOSYLATED AND O-GLYCOSYLATED [J].
CORTI, A ;
MERLI, S ;
BAGNASCO, L ;
DAMBROSIO, F ;
MARINO, M ;
CASSANI, G .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1995, 15 (02) :143-152
[5]  
DELEAN A, 1978, AM J PHYSIOL, V235, P97
[6]  
DING AH, 1989, J BIOL CHEM, V264, P3924
[7]  
ENGELMANN H, 1990, J BIOL CHEM, V265, P1531
[8]   ISOLATION, RENATURATION, AND FORMATION OF DISULFIDE BONDS OF EUKARYOTIC PROTEINS EXPRESSED IN ESCHERICHIA-COLI AS INCLUSION-BODIES [J].
FISCHER, B ;
SUMNER, I ;
GOODENOUGH, P .
BIOTECHNOLOGY AND BIOENGINEERING, 1993, 41 (01) :3-13
[9]   PURIFICATION AND CHARACTERIZATION OF AN INHIBITOR (SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR) FOR TUMOR-NECROSIS-FACTOR AND LYMPHOTOXIN OBTAINED FROM THE SERUM ULTRAFILTRATES OF HUMAN CANCER-PATIENTS [J].
GATANAGA, T ;
HWANG, CD ;
KOHR, W ;
CAPPUCCINI, F ;
LUCCI, JA ;
JEFFES, EWB ;
LENTZ, R ;
TOMICH, J ;
YAMAMOTO, RS ;
GRANGER, GA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (22) :8781-8784
[10]   CLONING OF HUMAN TUMOR-NECROSIS-FACTOR (TNF) RECEPTOR CDNA AND EXPRESSION OF RECOMBINANT SOLUBLE TNF-BINDING PROTEIN [J].
GRAY, PW ;
BARRETT, K ;
CHANTRY, D ;
TURNER, M ;
FELDMANN, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (19) :7380-7384